Steph & Co. grew its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 22.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,582 shares of the healthcare conglomerate’s stock after purchasing an additional 292 shares during the period. UnitedHealth Group makes up 0.5% of Steph & Co.’s holdings, making the stock its 27th largest position. Steph & Co.’s holdings in UnitedHealth Group were worth $813,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Advocacy Wealth Management Services LLC boosted its stake in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. boosted its stake in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 30 shares during the last quarter. Rise Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $38,000. Evolution Advisers Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter worth about $38,000. Finally, Cordant Inc. purchased a new position in UnitedHealth Group during the first quarter worth approximately $45,000. 87.25% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of brokerages have issued reports on UNH. Morgan Stanley increased their price target on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Loop Capital began coverage on UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target on the stock. Mizuho increased their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. SVB Leerink raised their target price on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Finally, Credit Suisse Group raised their target price on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $586.40.
UnitedHealth Group Price Performance
UNH stock opened at $517.46 on Friday. The business has a fifty day moving average of $530.11 and a two-hundred day moving average of $512.45. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The stock has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a price-to-earnings-growth ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same quarter last year, the firm earned $4.70 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were paid a dividend of $1.65 per share. The ex-dividend date was Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.46%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.